Tactile Systems Technology (TCMD) Change in Accured Expenses (2015 - 2026)
Tactile Systems Technology's (TCMD) quarterly Change in Accured Expenses came in at -$8.3 million in Q1 2026, down 19.2% year-on-year from -$10.3 million in Q1 2025, and down 279.25% on a QoQ basis from $4.7 million in Q4 2025.
Tactile Systems Technology (TCMD) Change in Accured Expenses (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 12 years of Change in Accured Expenses data on file, last reported at -$8.3 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 19.2% year-over-year to -$8.3 million in Q1 2026; TTM through Mar 2026 was $112000.0, a 219.15% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 28.31% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$8.3 million, down from $4.7 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for TCMD reached as high as $4.8 million in Q4 2024 and fell as low as -$8.3 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged -$64588.2 across 5 years, with a median of $1.4 million in 2022.
- Across the five-year window, Change in Accured Expenses jumped 7431.58% in 2022 and plunged 112.04% in 2023, its largest moves.
- Year by year, Change in Accured Expenses stood at $3.5 million in 2022, then sank by 43.12% to $2.0 million in 2023, then soared by 141.25% to $4.8 million in 2024, then slipped by 3.85% to $4.7 million in 2025, then slumped by 279.25% to -$8.3 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$8.3 million in Q1 2026, $4.7 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tactile Systems Technology | 619.08 Mn | 528.88 Mn | 57.61 Mn | -8.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.34 Mn |
| Mar 31, 2026 | -8.34 Mn |
| Dec 31, 2025 | 4.65 Mn |
| Dec 31, 2025 | 4.65 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.75 Mn |
| Mar 31, 2025 | -6.99 Mn |
| Mar 31, 2025 | -6.99 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Dec 31, 2024 | 4.84 Mn |
| Sep 30, 2024 | 996,000.00 |
| Sep 30, 2024 | 996,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | -5.77 Mn |
| Mar 31, 2024 | -5.77 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |